Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: Despite progress in identifying molecular pathophysiological processes in schizophrenia, valid biomarkers are lacking for both the disease and treatment response. METHODS: This comprehensive review summarises recent efforts to identify molecular mechanisms on the level of protein and gene expression and epigenetics, including DNA methylation, histone modifications and micro RNA expression. Furthermore, it summarises recent findings of alterations in lipid mediators and highlights inflammatory processes. The potential that this research will identify biomarkers of schizophrenia is discussed. RESULTS: Recent studies have not identified clear biomarkers for schizophrenia. Although several molecular pathways have emerged as potential candidates for future research, a complete understanding of these metabolic pathways is required to reveal better treatment modalities for this disabling condition. CONCLUSIONS: Large longitudinal cohort studies are essential that pair a thorough phenotypic and clinical evaluation for example with gene expression and proteome analysis in blood at multiple time points. This approach might identify biomarkers that allow patients to be stratified according to treatment response and ideally also allow treatment response to be predicted. Improved knowledge of molecular pathways and epigenetic mechanisms, including their potential association with environmental influences, will facilitate the discovery of biomarkers that could ultimately be effective tools in clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STRING v9.1: protein-protein interaction networks, with increased coverage and integration
Franceschini, A., Szklarczyk, D., Frankild, S., Kuhn, M., Simonovic, M., Roth, A., Lin, J., Minguez, P., Bork, P., von Mering, C., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1094 · Cited by 4,398
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
Dalmau, J., Gleichman, A. J., Hughes, E. G., Rossi, J. E., Peng, X., Lai, M., Dessain, S. K., Rosenfeld, M. R., Balice-Gordon, R., & Lynch, D. R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70224-2 · Cited by 3,488
Pro-resolving lipid mediators are leads for resolution physiology
Serhan, C. N. (2014) · Nature · doi:10.1038/nature13479 · Cited by 3,041 · cited 1×
“Omega-3 fatty acids (docosahexaenoic acid, DHA, 22:6n-3, and eicosapentaenoic acid, EPA, 20:5n-3) have recently been shown to form anti-inflammatory/ immuno-resolving signalling lipids that counterbalance the activity of inflammatory signalling lipids (Serhan 2014; Serhan et al. 2015).”
BackgroundTan, M., Luo, H., Lee, S., Jin, F., Yang, J. S., Montellier, E., Buchou, T., Cheng, Z., Rousseaux, S., Rajagopal, N., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.008 · Cited by 1,902 · cited 3×
“(2 01 6) and small protein (ubiquitin, SUMO) modification of specific lysine residues, as well as arginine (R) methylation and citrullination, serine (S) phosphorylation, tyrosine (T) hydroxylation and several others (Kouzarides 2007; Taverna et al. 2007; Tan et al. 2011).”
BackgroundMeta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
Miller, B. J., Buckley, P., Seabolt, W., Mellor, A., & Kirkpatrick, B. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.04.013 · Cited by 1,742 · cited 1×
“Increased levels of pro-inflammatory cytokines are the most consistent immunological finding in schizophrenia (Kim et al. 2004; Miller et al. 2011).”
BackgroundCommon variants conferring risk of schizophrenia
†Genetic Risk and Outcome in Psychosis (GROUP), Stefansson, H., Ophoff, R. A., Steinberg, S., Andreassen, O. A., Cichon, S., Rujescu, D., Werge, T., Pietiläinen, O. P. H., Mors, O., et al. (2009) · Nature · doi:10.1038/nature08186 · Cited by 1,677 · cited 2×
“Since its first publication in 2009 (Stefansson et al. 2009), the psychiatric genomics consortium (PGC, http://www.”
BackgroundKynurenines in the mammalian brain: when physiology meets pathology
Schwarcz, R., Bruno, J. P., Muchowski, P. J., & Wu, H.-Q. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3257 · Cited by 1,530
Genome-wide association analysis identifies 13 new risk loci for schizophrenia
Multicenter Genetic Studies of Schizophrenia Consortium, Ripke, S., Psychosis Endophenotypes International Consortium, Wellcome Trust Case Control Consortium 2, O'Dushlaine, C., Chambert, K., Moran, J. L., Kähler, A. K., Akterin, S., Bergen, S. E., et al. (2013) · Nature Genetics · doi:10.1038/ng.2742 · Cited by 1,496
Self-citationMicroglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease
Prinz, M., & Priller, J. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3722 · Cited by 1,329 · cited 2×
“…al. 2012), although it may also be interpreted as a non-inflammatory deregulation of microglia gene expression networks that control microglial functions implicated in synaptic and axonal pruning processes and ultimately fine tune neuronal networks during young adulthood (Prinz and Priller 2014).”
BackgroundImplication of sperm RNAs in transgenerational inheritance of the effects of early trauma in mice
Gapp, K., Jawaid, A., Sarkies, P., Bohacek, J., Pelczar, P., Prados, J., Farinelli, L., Miska, E., & Mansuy, I. M. (2014) · Nature Neuroscience · doi:10.1038/nn.3695 · Cited by 1,306
Cited by
Smigielski, L., Jagannath, V., Rössler, W., Walitza, S., & Grünblatt, E. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0601-3 · Cited by 168
Self-citationHDAC1 links early life stress to schizophrenia-like phenotypes
Bahari-Javan, S., Varbanov, H., Halder, R., Benito, E., Kaurani, L., Burkhardt, S., Anderson-Schmidt, H., Anghelescu, I., Budde, M., Stilling, R. M., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613842114 · Cited by 101
Self-citationBDNF as a Biomarker of Cognition in Schizophrenia/Psychosis: An Updated Review
Nieto, R. R., Carrasco, A., Corral, S., Castillo, R., Gaspar, P. A., Bustamante, M. L., & Silva, H. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.662407 · Cited by 83
“Now Is a Time for Optimism”: The Politics of Personalized Medicine in Mental Health Research
Rüppel, J. (2019) · Science, Technology, & Human Values · doi:10.1177/0162243919845049 · Cited by 12
Metadata
- Authors
- Schmitt, A., Martins-de-Souza, D., Akbarian, S., Cassoli, J. S., Ehrenreich, H., Fischer, A., Fonteh, A., Gattaz, W. F., Gawlik, M., Gerlach, M., Grünblatt, E., Halene, T., Hasan, A., Hashimoto, K., Kim, Y.-K., Kirchner, S.-K., Kornhuber, J., Kraus, T. F. J., Malchow, B., Nascimento, J. M., Rossner, M., Schwarz, M., Steiner, J., Talib, L., Thibaut, F., Riederer, P., Falkai, P., & The Members of the WFSBP Task Force on Biological Markers
- Venue
- The World Journal of Biological Psychiatry
- Publisher
- Informa UK Limited
- Published
- 2016-10-26
- Volume
- 18
- Issue
- 5
- Pages
- 330-356
- ISSN
- 1562-2975 (ISSN-L)
- 1814-1412
- OpenAlex
- W2539480257
- Cited by
- 38
- References
- 52
- FWCI
- 5.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms. https://app.cochat.ai/papers/10.1080/15622975.2016.1224929
- The paper
- Schmitt, A., Martins-de-Souza, D., Akbarian, S., Cassoli, J. S., Ehrenreich, H., Fischer, A., Fonteh, A., Gattaz, W. F., Gawlik, M., Gerlach, M., Grünblatt, E., Halene, T., Hasan, A., Hashimoto, K., Kim, Y.-K., Kirchner, S.-K., Kornhuber, J., Kraus, T. F. J., Malchow, B., . . . The Members of the WFSBP Task Force on Biological Markers. (2017). Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms. The World Journal of Biological Psychiatry. https://doi.org/10.1080/15622975.2016.1224929
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.